BioXcel Therapeutics Stock (NASDAQ: BTAI) stock price, news, charts, stock research, profile.
You can purchase shares of BioXcel Therapeutics (NASDAQ:BTAI) through any online brokerage.
Other companies in BioXcel Therapeutics’s space includes: Vincerx Pharma (NASDAQ:VINC), Monopar Therapeutics (NASDAQ:MNPR), Bolt Biotherapeutics (NASDAQ:BOLT), Geovax Labs (NASDAQ:GOVX) and Tonix Pharmaceuticals (NASDAQ:TNXP).
BioXcel Therapeutics has a consensus price target of $7.43.
The stock price for BioXcel Therapeutics (NASDAQ: BTAI) is $0.56 last updated October 2, 2024 at 5:54 AM EDT.
There are no upcoming dividends for BioXcel Therapeutics.
BioXcel Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for BioXcel Therapeutics.
BioXcel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.